Why Medical Toxicology?
- 期刊名称Drug Safety
- 作者Susan M. Pond,L. F. Prescott,Lewis Goldfrank
- 卷第1卷
- 期第1期
- 印刷ISSN0114-5916
- 电子ISSN1179-1942
- 文件大小229.75KB
- 发表时间1986-02
- DOI10.1007/BF03259823
- 页码1-2
Long-term experience (6 years) with simvastatin in patients with heterozygous familial hypercholesterolaemiaR.E. Knops; A.A. Kroon; M.J.T.M. Mol; P.M.J. Stuyt; A.F.H. Stalenhoef · 1995
Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long-Term Experience in a Large Group of Patients with HypercholesterolemiaLeiv Ose; Michael H. Davidson; William Insull; Mei Wu; Ann C. Tate; Michael R. Melino; Michele Mercuri; Yale B. Mitchel; Evan A. Stein; Johannes J. P. Kastelein; Russell S. Scott; Donald B. Hunninghake; Santiago Campodonico; Ivan D. Escobar; Michael E. Stepanavage; Helmut G. Schrott · 2000
Isoniazid OverdoseMaw, Graeme; Aitken, Peter · Clinical Drug Investigation · 2003
AcarboseLaube, Heiner · Clinical Drug Investigation · 2002
Heterogeneity of Chronic PainVellucci, Renato · Clinical Drug Investigation · 2012
CefdinirAppelbaum, P.C. · Clinical Drug Investigation · 1995
Pain BiomarkersMarchi, Antonio; Vellucci, Renato; Mameli, Sergio; Rita Piredda, Anna; Finco, Gabriele · Clinical Drug Investigation · 2009
IobitridolMcCormack, Paul L. · Clinical Drug Investigation · 2013
Candesartan Cilexetil 32Bramlage, Peter; Buhck, Hartmut; Zemmrich, Claudia · Clinical Drug Investigation · 2014
Closing RemarksKudo, Masatoshi · Clinical Drug Investigation · 2012